Kappa light chain predominance in serum and cerebrospinal fluid from human immunodeficiency virus type 1 (HIV-1)-infected patients

Luigi M E Grimaldi, Antonella Castagna, Davide Maimone, Gian Vito Martino, Alberto Dolci, Raffaele Pristera, Adriano Lazzarin, Raymond P. Roos

Research output: Contribution to journalArticlepeer-review

Abstract

We measured kappa/lambda light chain ratios of Ig and IgG in 41 serum and 34 cerebrospinal fluid (CSF) samples from 47 patients at different clinical stages of human immunodeficiency virus type 1 (HIV-1) infection and in serum and CSF samples from control subjects. Both ratios were more elevated in HIV-1 seropositive subjects than controls. The elevation was more evident in samples from asymptomatic seropositive patients (ASP) than those from patients with acquired immunodeficiency syndrome (AIDS). In addition, there was a statistically significant elevation of Ig kappa/lambda ratios in ASP CSF compared to serum. We also delineated the light chain composition of oligoclonal IgG bands (OCB) by isoelectric focusing followed by immunofixation in CSF and serum samples from selected ASP and patients with AIDS who had neurological involvement. Five of six AIDS and all seven ASP samples had IgG OCB exclusively or predominantly of the kappa type. Four IgG OCB of the lambda type and one free lambda chain band were seen in CSF from a pediatric AIDS patient. The presence of an abnormally elevated kappa/lambda ratio correlated with the presence of IgG kappa OCB (p

Original languageEnglish
Pages (from-to)259-268
Number of pages10
JournalJournal of Neuroimmunology
Volume32
Issue number3
DOIs
Publication statusPublished - 1991

Keywords

  • (HIV) infection
  • Human immunodeficiency virus
  • Immunoglobulin light chain
  • Isoeletric focusing
  • Oligoclonal band

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Clinical Neurology
  • Neurology

Fingerprint

Dive into the research topics of 'Kappa light chain predominance in serum and cerebrospinal fluid from human immunodeficiency virus type 1 (HIV-1)-infected patients'. Together they form a unique fingerprint.

Cite this